• Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases.

Jung J*, Jeong NY*

Neural Regen Res. 2014. 9(24):2119-2121.

​

• GRS defective axonal distribution as a potential contributor to distal spinal muscular atrophy type V pathogenesis in a new model of GRS-associated neuropathy.

Seo AJ, Park BS, Jung J*

J Chem Neuroanat. 2014. 61-62:132-139.

​

• Adenoviral-mediated mouse model of motor impairment in distal spinal muscular atrophy type V.

Seo AJ, Park BS, Jeong NY, Kim D, Kim S, Park C, Jung J*, Huh Y*

Anim. Cells Syst. 2014. 18(5):311-317.

​

• ATP release through lysosomal exocytosis from peripheral nerves: the effect of lysosomal exocytosis on peripheral nerve degeneration and regeneration after nerve injury.

Jung J*, Jo HW, Kwon H, Jeong NY*

Biomed Res Int. 2014. 2014:936891. 

​

• Clinical neuroanatomy and neurotransmitter-mediated regulation of penile erection.

Jung J*, Jo HW, Kwon H, Jeong NY*

Int Neurourol J. 2014. 18(2):58-62.

​

• Adenosine 5'-triphosphate (ATP) inhibits schwann cell demyelination during Wallerian degeneration.

Shin YH, Chung HJ, Park C, Jung J*, Jeong NY*

Cell Mol Neurobiol. 2014. 34(3):361-368.

​

• A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D).

Seo AJ, Shin YH, Lee SJ, Kim D, Park BS, Kim S, Choi KH, Jeong NY, Park C, Jang JY, Huh Y*, Jung J*

J Mol Histol. 2014. 45(2):121-128.

​

• Related expressional change of HIF-1α to the neuroprotective activity of exendin-4 in transient global ischemia.

Jin J, Kang HM, Jung J, Jeong JW, Park C*

Neuroreport. 2014. 25(1):65-70.